Find your next paid study

Lindenwood UniversityNCT07387991

Actual pay is set by the research site.

Observational

Deep Brain Stimulation Neural Recordings of Varied Stimulation During Sleep in Parkinson's Disease - The DREAMS-PD Study

This study employs an exploratory, prospective, single center, naturalistic clinical trial design with a randomized crossover intervention.

Parkinson Disease

The Cleveland ClinicNCT07110376

Actual pay is set by the research site.

Phase 4

Evaluation of Mechanism(s)Limiting Expiratory Airflow in Chronic, Stable Asthmatics Who Are Non-smokers

The purpose of this study is to evaluate the site and mechanisms responsible for expiratory airflow limitation in chronic, treated, non-smoking, stable asthmat…

Asthma

Gelb, Arthur F., M.D.NCT01225913

~$25 – $1,500

Actual pay is set by the research site.

Observational

SDM POSSIBLE: A Cluster RCT of a Breast Cancer Treatment Decision Aid for Women 70+ With Low-Risk Stage I Breast Cancers

Investigators aim to conduct a type 1 hybrid effectiveness-implementation surgeon-level cluster randomized clinical trial (RCT) of a multi-level intervention, …

Breast Cancer

Beth Israel Deaconess Medical CenterNCT06896474

Actual pay is set by the research site.

CC-486 and Venetoclax for Acute Myeloid Leukemia

This is an open label, dose escalation Phase I single institution pilot study for relapsed and refractory AML patients using CC-486 (oral azacitidine) with ven…

AML

University of Colorado, DenverNCT05287568

~$150 – $3,000

Actual pay is set by the research site.

Phase 2

Phase II Biomarker Study of BND-22 in Combination With Cemiplimab in Solid Tumors

To study possible biomarkers that may be related to how SAR444881 works (either alone or when combined with cemiplimab) in participants with solid tumors.

Solid Tumors

M.D. Anderson Cancer CenterNCT06651593

~$75 – $2,000

Actual pay is set by the research site.

Observational

Using Shared Decision Making to Improve Family Media Use Planning

Investigators will conduct a pilot randomized controlled trial assessing the efficacy and feasibility of the newly developed Family Media Check-In (FMC).

Adolescent Behavior

Seattle Children's HospitalNCT05722535

Actual pay is set by the research site.

Phase 2

MethoTRExATE in MyelOpRolifErative Neoplasms (TREATMORE) Trial

Low-dose MTX is a widely used, inexpensive, and safe therapy used for decades and is well tolerated by patients with rheumatologic diseases. Recently, it was i…

Polycythemia Vera (PV)Essential Thrombocythemia (ET)Myelofibrosis (MF)

Icahn School of Medicine at Mount SinaiNCT06541249

~$75 – $2,000

Actual pay is set by the research site.

Biomarker Approach to Screening for the Early Detection of HPV-related Oropharyngeal Cancer (BASH OPC)

Investigators seek to determine the sensitivity and specificity of a combined HPV 16 DNA and host gene methylation oral biomarker panel to distinguish early Or…

Oropharyngeal CancerHPV-Related Carcinoma

H. Lee Moffitt Cancer Center and Research InstituteNCT06305676

Actual pay is set by the research site.

Reduction of Severity and Duration of Pediatric Gastroenteritis Through Amino Acid Fortified Oral Rehydration Therapy

The goal of this clinical trial is to compare amino acid-fortified oral rehydration therapy (ORT) to the standard of care ORT in pediatric patients with acute …

Acute Gastroenteritis

Paul A BreslinNCT06137014

~$150 – $4,500

Actual pay is set by the research site.

Gastroesophageal Adenocarcinoma

Response Adapted Neoadjuvant Therapy in Gastroesophageal Cancers (RANT-GC Trial) - a Phase Ib Feasibility Trial

This is a phase 1b prospective, single arm, open-label trial determining the efficacy and feasibility of using a response-guided approach to help guide neoadju…

University of California, IrvineNCT05733689

~$150 – $3,000

Actual pay is set by the research site.

Refractory Solid TumorsRelapsed Solid TumorsRelapsed Neuroblastoma+3 more

A Phase 1/2 Clinical Trial of the Novel Topoisomerase I Inhibitor PEEL-224 as a Single Agent and in Combination With Vincristine and Temozolomide in Children With Refractory, Progressive or Relapsed Solid Tumors

The phase 1 primary objective is to determine the pediatric recommended phase 2 dose (RP2D) of PEEL-224 as a single agent (phase 1A) and in combination with vi…